suzuki,
I back up any statement of fact with a citation, so that anyone can check the source and whether that source is credible.
you cannot come here with unsubstantiated information about Panco showing something that LAPACT doesn't show without substantiating that information.
I'm going to call it out every time you do!
As per previously cited sources, occurrence of adverse events in the Gem+abr (LAPACT) and Gem+abr+oncosil (PANCO) trials.
| | LAPACT | PANCO |
|---|
| 1 | Anaemia | 46 | 30 |
|---|
| 2 | Neutropenia | 42 | 46 |
|---|
| 3 | Throbocytopenia | 25 | 26 |
|---|
| 4 | Abdominal pain | 18 | 54 |
|---|
| 5 | Constipation | 30 | 48 |
|---|
| 6 | Diarrhoea | 45 | 60 |
|---|
| 7 | Nausea | 44 | 60 |
|---|
| 8 | Vomiting | 28 | 34 |
|---|
| 9 | Fatigue | 50 | 78 |
|---|
| 10 | Perpheral Oedema | 44 | 50 |
|---|
| 11 | Pyrexia | 38 | 34 |
|---|
| 12 | Weight Loss | 11 | 28 |
|---|
| 13 | Decreased Appetite | 43 | 38 |
|---|
| 14 | Hypokalaemia | 13 | 20 |
|---|
| 15 | Peripheral Neuropathy | 28 | 36 |
|---|
| 16 | Alopecia | 54 | 42 |
|---|
| 17 | Rash | 8 | 26 |
|---|
| 18 | | | |
|---|
| 19 | AVERAGE | 33 | 42 |
|---|
You see, with the above information I can substantiate a claim that there is no difference in adverse effects between LAPACT and Panco or that under Oncosil, patients are more likely to suffer (I can make that second claim stronger with a statistical analysis).
Your turn...
(20min delay)